RESUMEN
BACKGROUND: In 2013, the Dominican Republic introduced 13-valent pneumococcal conjugate vaccine (PCV13) using a 3-dose schedule (at 2, 4 and 12 months of age). We evaluated the impact of PCV13 on serotypes causing pneumococcal pneumonia with pleural effusion. METHODS: Surveillance data after PCV13 introduction (July 2014 to June 2016) were compared with data before PCV13 introduction (July 2009 to June 2011). Cases were defined as radiologic evidence of pneumonia with pleural effusion in a child aged <15 years. Pneumococcus was detected in pleural fluid by either culture or polymerase chain reaction, and serotyping was performed. The Ministry of Health's PCV13 uptake data for 2014-2016 were obtained. RESULTS: The prevalence of pneumococcus among cases was similar before and after PCV13 introduction (56.4% and 52.8%, respectively). The proportion of pneumococcal cases caused by vaccine serotypes was 86% for children <2 years old both before and PCV13 introduction. Compared with before PCV13, serotype 14 accounted for a smaller (28% vs 13%, respectively; P = .02) and serotype 1 for a larger (23% vs 37%; P = .09) proportion of pneumococcal cases after PCV13 introduction. National uptake for the first, second, and third PCV13 doses was 94%, 81%, and 28%, respectively, in 2014 and 75%, 61%, and 26% in 2015. DISCUSSION: While the decrease in pneumococcal pneumonia with pleural effusion caused by serotype 14 may reflect an early effect of PCV13 implementation, other vaccine serotypes, including serotype 1, are not well controlled. Better PCV13 coverage for all 3 doses is needed.
Asunto(s)
Infecciones Neumocócicas/epidemiología , Vacunas Neumococicas/administración & dosificación , Vacunas Neumococicas/efectos adversos , Neumonía Neumocócica/epidemiología , Vacunas Conjugadas/efectos adversos , Niño , Preescolar , República Dominicana/epidemiología , Femenino , Humanos , Lactante , Masculino , Derrame Pleural/epidemiología , Derrame Pleural/etiología , Infecciones Neumocócicas/complicaciones , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas/inmunología , Neumonía Neumocócica/complicaciones , Neumonía Neumocócica/prevención & control , Complicaciones Posoperatorias , Prevalencia , Serogrupo , Streptococcus pneumoniae/inmunología , Streptococcus pneumoniae/aislamiento & purificación , Vacunación , Vacunas Conjugadas/administración & dosificación , Vacunas Conjugadas/inmunologíaRESUMEN
BACKGROUND: Streptococcus pneumoniae is the most frequent bacterial causative agent of pneumonia. Due to its significant contribution to the morbidity and mortality profile and the country's economy, the 10-valent pneumococcal vaccine (PCV10) was introduced in Brazil in 2010. Brazil is divided into five administrative regions which differ in social-economic indices among each other. Estimates of PCV10 impact on hospitalization rates due to pneumonia stratified by distinct Brazilian regions are limited. We assessed this issue. METHODS: This is a population-based ecological investigation. Data about hospitalizations due to pneumonia, asthma or urinary tract infection (UTI) among patients aged under 20 years in the pre-exposure (2003-2009) and in the post-exposure (2011-2017) periods were retrieved from the National Health System - Hospital Information System (SIH-SUS) database. The total resident population by age group in each year was retrieved from the Brazilian Institute for Geography and Statistics database. Hospitalization rates were estimated for each Brazilian region and the rates obtained in the pre-exposure and in the post-exposure periods were compared by Prais-Winsten regression. The Human Development Index (HDI) evolved differently in the distinct regions during the study period. RESULTS: Overall, hospitalization rates due to pneumonia declined by 34.5%. Similar trends were observed for hospitalization rates due to asthma and UTI. The same pattern was observed in each Brazilian region. However, the North region was the only one that presented an exponential incidence decline pattern, which could be explained by PCV10 implementation (declined by 10.8% in the quadratic regression, p < 0.01). Only in the North region, significant decline was observed among patients aged 0-4 years (-12.5%; p = 0.01), 5-9 years (-38.5%; p < 0.01) or 10-14 years (-10.7%; p = 0.03). CONCLUSION: Significant variation in the downward trend of hospitalization rate was only found in the North region, which evolved from very low HDI in 2003; medium HDI in 2010 to high HDI in 2017.
Asunto(s)
Infecciones Neumocócicas , Neumonía Neumocócica , Adulto , Brasil/epidemiología , Niño , Preescolar , Hospitalización , Humanos , Programas de Inmunización , Lactante , Recién Nacido , Vacunas Neumococicas , Neumonía Neumocócica/epidemiología , Neumonía Neumocócica/prevención & control , Adulto JovenRESUMEN
Resumen: Introducción: neumonía necrotizante (NN) es una complicación frecuente en niños hospitalizados por neumonía adquirida en la comunidad (NAC), caracterizada por importante morbilidad. En 2009, se elaboró una definición de caso, que permitió unificar criterios y racionalizar recursos en la asistencia de estos niños. Objetivo: describir características clínicas y evolutivas de niños que desarrollaron NN en los últimos 10 años. Metodología: estudio descriptivo de niños hospitalizados por NN entre 1/1/2009 y 31/12/2018. Definición de caso: neumatoceles y uno o más de los siguientes criterios: mal estado general, fiebre persistente o recurrente, leucocitosis mayor a 30.000 o menor a 5.000/mm3, proteína C reactiva mayor a 120 mg/dl, láctico deshidrogenasa en líquido pleural mayor a 2.500 UI/L y/o fístula broncopleural (FBP). Se describieron características epidemiológicas, clínicas, etiológicas y evolutivas. Resultados: se diagnosticó NN en 197 niños (7,92% de las hospitalizaciones por NAC), con número anual de casos y tasas/10.000 egresos variables. La mediana de edad fue de 25 meses; 89,8% eran sanos. La fiebre previa al diagnóstico tuvo mediana de cinco días. Tenían neumonía multilobar 58%, insuficiencia respiratoria 62%, sepsis 19%, empiema 80% y fístula bronquio-pleural 51%. Persistieron con fiebre mediana por siete días. Requirieron cuidados intensivos 46% y asistencia ventilatoria mecánica 18%. Los reactantes de fase aguda al ingreso fueron elevados. Se identificó agente etiológico en 102 casos, S. pneumoniae en 92. Fallecieron dos niños. Conclusiones: NN fue una complicación frecuente en niños hospitalizados por NAC. La presentación clínica y la evolución fueron graves. La identificación etiológica fue elevada, la mayoría correspondió a S. pneumoniae. La mortalidad fue baja.
Summary: Introduction: necrotizing pneumonia (NP) is a complication of community-acquired pneumonia (CAP) in hospitalized children, with significantly high morbidity. A case definition was devised in 2009, which enabled physicians to unify criteria and rationalize resources for the assistance of children with NP. Objective: describe clinical characteristics and evolution of children who developed NP. Methodology: descriptive study, NP hospitalized children between 1/1/2009 and 12/31/2018. Case definition: pneumatoceles and one or more of the following criteria: malaise, persistent/recurrent fever, white blood cell count over 30,000 or less than 5.000/mm3, C-reactive protein over 120 mg/dL, lactic dehydrogenase in pleural fluid over 2,500UI/L and/or bronchopleural fistula (BPF). Clinical, epidemiological, etiological and evolutionary characteristics were described. Results: NP was diagnosed in 197 children (7.92% of CAP hospitalizations), with variable annual cases and annual rate/10,000 discharges. Children had a median age of 25 months; 89.8% were previously healthy. They presented fever prior to diagnosis, median 5 days, multilobar pneumonia 58%, respiratory failure 62%, sepsis 19%, empyema 80% and BPF 51%, persistent fever median 7 days. 46% required intensive care and 18% required assisted mechanical ventilation. Acute phase reactants on admission were high. An etiological agent was identified in 102 cases, S.pneumoniae in 92. Two children died. Conclusions: NP was a frequent complication in CAP hospitalized children. Clinical presentation and evolution were severe. The etiological identification was high, most of them corresponded to S. pnuemoniae. Mortality was low.
Resumo: Introdução: a pneumonia necrosante (PN) é uma complicação da pneumonia adquirida na comunidade (PAC) em crianças hospitalizadas, com morbidade significativamente elevada. Em 2009, elaborou-se uma definição de caso, que possibilitou aos médicos unificar critérios e racionalizar recursos para o atendimento à criança com PN. Objetivo: descrever as características clínicas e evolutivas de crianças que desenvolveram PN nos últimos 10 anos. Metodologia: estudo descritivo de crianças internadas por PN entre 01/01/2009 e 31/12/2018. Definição de caso: pneumatoceles e um ou mais dos seguintes critérios: mau estado geral, febre persistente ou recorrente, leucocitose superior a 30.000 ou inferior a 5.000 / mm3, proteína C reativa superior a 120 mg / dl, desidrogenase láctica no líquido pleural superior 2.500 UI / L e / ou fístula broncopleural (BPF). Descreveram-se características epidemiológicas, clínicas, etiológicas e evolutivas. Resultados: a PN foi diagnosticada em 197 crianças (7,92% das internações por PAC), com número de casos e taxas anuais variáveis/10.000 altas. A idade média foi de 25 meses; 89,8% eram saudáveis. A febre antes do diagnóstico teve uma mediana de 5 dias. Eles tinham 58% de pneumonia multilobar, 62% de insuficiência respiratória, 19% de sepse, 80% de empiema e 51% de FBP. Eles persistiram com febre mediana por 7 dias. 46% necessitaram de cuidados intensivos e 18% de assistência ventilatória mecânica. Os reagentes de fase aguda na admissão foram elevados. Em 102 casos foi identificado um agente etiológico, S. pneumoniae em 92. 2 crianças morreram. Conclusões: NP é uma complicação frequente em crianças hospitalizadas por PAC. O quadro clínico e a evolução foram graves. A identificação etiológica foi alta, a maioria correspondeu a S. pneumoniae. A mortalidade foi baixa.
RESUMEN
BACKGROUND: The aim of this paper is to estimate the burden of hospitalization for community-acquired pneumonia and pneumococcal pneumonia at a tertiary level hospital in the Spanish National Health System. METHODS: A retrospective study which compiles data from the Minimum Data Set using clinical codes of the International Code of Diseases, as well as the hospitalization rate index per thousand inhabitants, the hospitalization rate per thousand population, mortality and fatality rate, using as denominator the demographic data of the population of the Health Area. RESULTS: The discharge of 5758 episodes coded with CIE codes 480 to 486 related to pneumonia, indicates an hospitalization rate of 3.54 people hospitalized per 1000 inhabitants, 65.34 % of all hospital admissions occured in Internal Medicine Services and Pneumology. The average hospital stay per year is 16.63 days. The crude death rate is 69.15 per 100 000 inhabitants and the fatality rate is 19.56 % being higher in adults over 65 years. CONCLUSIONS: Despite the current therapeutic and preventive measures, the incidence and mortality of community-acquired pneumonia in adults remains high, which justifies the strengthening and awareness to address new strategies and prevention such as vaccination.
Introducción: el objetivo de este trabajo es estimar la carga de hospitalización por neumonía adquirida en la comunidad y neumonía neumocócica en un hospital de nivel terciario del Sistema Nacional de Salud Español. Métodos: estudio retrospectivo en el que se recogen los datos del Conjunto Mínimo de Datos Básicos que usa códigos clínicos del Código Internacional de Enfermedades, asi como el índice de hospitalización por mil habitantes, la tasa de hospitalización por mil habitantes, el índice de mortalidad y la tasa de letalidad, usando como denominador los datos demográficos de la población del Área de Salud. Resultados: la descarga de 5758 episodios codificados con los códigos CIE 480 a 486 relativos a neumonía, señalan un índice de hospitalización de 3.54 personas hospitalizadas por cada 1000 habitantes, 65.34% del total de ingresos hospitalarios se produce en los Servicios de Medicina Interna y de Neumología. La estancia media hospitalaria por año es de 16.63 días. La tasa bruta de mortalidad es de 69.15 cada 100 000 y la tasa de letalidad de 19.56%, siendo más elevadas en adultos mayores de 65 años. Conclusiones: a pesar de las medidas terapéuticas y preventivas actuales, la incidencia y la mortalidad por neumonía adquirida en la comunidad en adultos se mantienen elevadas, lo que justifica fortalecer y abordar nuevas estrategias de concienciación y prevención.
Asunto(s)
Costo de Enfermedad , Hospitalización/estadística & datos numéricos , Neumonía Neumocócica/epidemiología , Centros de Atención Terciaria/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/terapia , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Neumonía Neumocócica/terapia , Estudios Retrospectivos , España/epidemiología , Adulto JovenRESUMEN
AbstractIntroduction: Ventilator-associated pneumonia (VAP) is a lung infection that occurs 48 hours or more after endotracheal intubation in patients undergoing mechanical ventilation.Objective: To use the Clinical Pulmonary Infection Score (CPIS) in order to identify the presence of VAP in patients with endotracheal intubation.Methods: Descriptive, cross-sectional study, which included 53 patients with mechanical ventilation, out of which only 11 met the selection criteria. Patients were assessed with the CPIS, as well as with their results of blood count, chest X-ray, and culture of endotracheal aspirates.Results: 81.9% were male, with a mean age of 65.09 ± 13.4 years, weight 75.7 ± 13.5 kg, height 1.61 ± 0.21 cm. The main cause of mechanical ventilation was neurological in 36.4%, and pulmonary in 27.3%. Of all the microorganisms isolated, the one with the highest estimated rate was Pseudomonas aeruginosa. Enterobacter cloacae and Pseudomonas aeruginosa showed drug resistance to all antibiotics.Conclusion: The use of the scale for evaluating patients with mechanical ventilation helps to identify the presence of ventilator-associated pneumonia.
Asunto(s)
Intubación Intratraqueal , Neumonía Asociada al Ventilador , Neumonía Neumocócica , Personal de Enfermería en Hospital , México , HumanosRESUMEN
We examined nasopharyngeal pneumococcal colonization density patterns surrounding acute respiratory illnesses (ARI) in young children in Peru. Pneumococcal densities were dynamic, gradually increasing leading up to an ARI, peaking during the ARI, and decreasing after the ARI. Rhinovirus co-infection was associated with higher pneumococcal densities.
Asunto(s)
Nasofaringe/microbiología , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/microbiología , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/microbiología , Streptococcus pneumoniae/aislamiento & purificación , Enfermedad Aguda , Carga Bacteriana , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Perú/epidemiología , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas/inmunología , Vigilancia de la Población , Infecciones del Sistema Respiratorio/prevención & control , Factores de Riesgo , Streptococcus pneumoniae/inmunologíaRESUMEN
Pneumococcal infections are important for their morbidity and economic burden, but there is no economical data from adults patients in Chile. Aims. Estimate direct medical costs of bacteremic pneumococcal pneumonia among adult patients hospitalized in a general hospital and to evaluate the sensitivity of ICD 10 discharge codes to capture infections from this pathogen. Methods. Analysis of hospital charges by components in a group of patients admitted for bacteremic pneumococcal pneumonia, correction of values by inflation and conversion from CLP to US$. Results. Data were collected from 59 patients admitted during 2005-2010, mean age 71.9 years. Average hospital charges for those managed in general wards reached 2,756 US$, 8,978 US$ for those managed in critical care units (CCU) and 6,025 for the whole group. Charges were higher in CCU (p < 0.001), and patients managed in these units generated 78.3% of the whole cost (n = 31; 52.5% from total). The median cost in general wards was 1,558 US$, and 3,993 in CCU. Main components were bed occupancy (37.8% of charges), and medications (27.4%). There were no differences associated to age, comorbidities, severity scores or mortality. No single ICD discharge code involved a S. pneumoniae bacteremic case (0% sensitivity) and only 2 cases were coded as pneumococcal pneumonia (3.4%). Conclusions. Mean hospital charges (~6,000 US dollars) or median values (~2,400 US dollars) were high, underlying the economic impact of this condition. Costs were higher among patients managed in CCU. Recognition of bacteremic pneumococcal infections by ICD 10 discharge codes has a very low sensitivity.
Las infecciones neumocócicas representan una gran carga de morbilidad y de gastos en salud en pacientes adultos pero no se dispone de datos que hayan evaluado su dimensión económica en Chile. Objetivo: Evaluar los gastos directos en un grupo de pacientes adultos hospitalizados por neumonía neumocóccica bacterémica en un hospital general y evaluar la sensibilidad de los códigos de egreso CIE 10 para capturar las infecciones por este patógeno. Métodos: Análisis de gastos por componentes de un grupo de pacientes atendidos por neumonía neumocóccica bacteriémica, actualización de gastos y conversión a US$. Resultados: Se rescató información de 59 pacientes atendidos entre el 2005-2010, con edad promedio de 71,9 años. El gasto promedio en sala fue de 2.756 US$, de 8.978 US$ en Unidades Críticas y de 6.025 US$ para el grupo total. Los gastos fueron mayores en Unidades Críticas (p < 0,001) y los pacientes en estas unidades (n = 31; 52,5% del total) generaron el 78,3% del gasto total observado. La mediana de gastos en sala fue de 1.558 US$ y de 3.993 US$ en el caso de Unidades Críticas. El 37,8% del gasto se originó por día-cama y 27,4% por medicamentos. No hubo diferencias por edad, co-morbilidades, scores de gravedad o mortalidad. Ningún código CIE 10 involucró bacteriemia por S. pneumoniae (Sensibilidad 0%) y sólo 2 casos fueron codificados como neumonía neumocóccica (3,4%). Conclusiones: El gasto promedio (aprox. 6.000 dólares americanos) y mediana (aprox. 2.400 dólares americanos) fueron elevados evidenciando la importancia económica de esta enfermedad. Los gastos fueron mayores en pacientes manejados en Unidades Críticas. La sensibilidad de los códigos CIE 10 fue baja para reconocer eventos de ENI en esta serie.
Asunto(s)
Humanos , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Adulto Joven , Neumonía Neumocócica/economía , Costos de Hospital/estadística & datos numéricos , Neumonía Neumocócica/mortalidad , Neumonía Neumocócica/terapia , Chile/epidemiología , Estudios Retrospectivos , Precios de Hospital , Hospitales Generales/economíaRESUMEN
A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship between respiratory diseases caused by influenza, pneumococcal diseases and cardiovascular events, and the role played by immunization strategies applied in cardiovascular prevention. The present statement summarizes the conclusions reached by the expertise of the aforementioned professionals. Systematic revisions imply consistent evidence that influenza and pneumococcal infection lead to acute myocardial infarction and cardiovascular death. Studies published during the last 15 years suggest that vaccination against influenza and S. pneumoniae reduce the risk of acute coronary syndromes. With the current evidence, and considering cost-effectiveness, reducing operating expenses and safety profile of the vaccines, scientific societies, national and international government health agencies strongly recommend incorporating immunization programs in those patients with chronic cardiovascular disease.
Asunto(s)
Síndrome Coronario Agudo/prevención & control , Gripe Humana/prevención & control , Infarto del Miocardio/prevención & control , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas/administración & dosificación , Vacunación/economía , Argentina , Enfermedades Cardiovasculares/prevención & control , Análisis Costo-Beneficio , Agencias Gubernamentales , Humanos , Inmunización/economía , Literatura de Revisión como AsuntoRESUMEN
OBJECTIVE: To describe the case-fatality rate (CFR) and risk factors of death in children with community-acquired acute pneumonia (CAP) in a pediatric university hospital. METHOD: A longitudinal study was developed with prospective data collected from 1996 to 2011. Patients aged 1 month to 12 years were included in the study. Those who left the hospital against medical orders and those transferred to ICU or other units were excluded. Demographic andclinical-etiological characteristics and the initial treatment were studied. Variables associated to death were determined by bivariate and multivariate analysis using logistic regression. RESULTS: A total of 871 patients were selected, of whom 11 were excluded; thus 860 children were included in the study. There were 26 deaths, with a CFR of 3%; in 58.7% of these, penicillin G was the initial treatment. Pneumococcus was the most common pathogen (50.4%). From 1996 to 2000, there were 24 deaths (93%), with a CFR of 5.8% (24/413). From 2001 to 2011, the age group of hospitalized patients was older (p = 0.03), and the number of deaths (p = 0.02) and the percentage of disease severity were lower (p = 0.06). Only disease severity remained associated to death in the multivariate analysis (OR = 3.2; 95%CI: 1.2-8.9; p = 0.02). CONCLUSION: When the 1996-2000 and 2001-2011 periods were compared, a significant reduction in CFR was observed in the latter, as well as a change in the clinical profile of the pediatric in patients at the institute. These findings may be related to the improvement in the socio-economical status of the population. Penicillin use did not influence CFR. .
OBJETIVO: Descrever a taxa de letalidade (TL) e os fatores de risco de óbito em crianças com pneumonia grave adquirida na comunidade (CAP) em um hospital universitário pediátrico. MÉTODO: Foi desenvolvido um estudo longitudinal com dados prospectivos coletados de 1996 a2011. Foram incluídos no estudo pacientes com idade entre 1 mês e 12 anos de idade. Foram excluídos aqueles que deixaram o hospital desconsiderando as recomendações médicas e aqueles transferidos para UTI ou outras unidades. Foram estudadas as características demográficas, clínicas e etiológicas e o tratamento inicial. As variáveis associadas a óbito foram determinadas por análise bivariada e multivariada utilizando regressão logística. RESULTADOS: Foi selecionado um total de 871 pacientes, dos quais 11 foram excluídos; assim, foram incluídas no estudo 860 crianças. Houve 26 óbitos, com uma TL de 3%; em 58,7% desses, penicilina G foi o tratamento inicial. Pneumococo foi o patógeno mais comum (50,4%). De 1996 a 2000, houve 24 óbitos (93%), com uma TL de 5,8% (24/413). De 2001 a 2011, a faixa etária de pacientes internados foi mais velha (p = 0,03) e o número de óbitos (p = 0,02) e o percentual de gravidade das doenças foram menores (p = 0,06). Apenas a gravidade das doenças continuou associada a óbito na análise multivariada (RC = 3,2; IC de 95%: 1,2-8,9; p = 0,02). CONCLUSÃO: Quando os períodos de 1996-2000 e 2001-2011 foram comparados, foi observada uma redução significativa na TL no último período, bem como uma alteração no perfil clínico dos pacientes hospitalizados no instituto. Esses achados podem estar relacionados à melhora na situação socioeconômica da população. O uso de penicilina não influenciou a TL. .
Asunto(s)
Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Mortalidad Hospitalaria , Neumonía/mortalidad , Brasil/epidemiología , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/mortalidad , Hospitalización/estadística & datos numéricos , Modelos Logísticos , Estudios Longitudinales , Análisis Multivariante , Estudios Prospectivos , Penicilina G/uso terapéutico , Neumonía/tratamiento farmacológico , Neumonía/epidemiología , Factores de RiesgoRESUMEN
OBJECTIVE: To describe the case-fatality rate (CFR) and risk factors of death in children with community-acquired acute pneumonia (CAP) in a pediatric university hospital. METHOD: A longitudinal study was developed with prospective data collected from 1996 to 2011. Patients aged 1 month to 12 years were included in the study. Those who left the hospital against medical orders and those transferred to ICU or other units were excluded. Demographic and clinical-etiological characteristics and the initial treatment were studied. Variables associated to death were determined by bivariate and multivariate analysis using logistic regression. RESULTS: A total of 871 patients were selected, of whom 11 were excluded; thus 860 children were included in the study. There were 26 deaths, with a CFR of 3%; in 58.7% of these, penicillin G was the initial treatment. Pneumococcus was the most common pathogen (50.4%). From 1996 to 2000, there were 24 deaths (93%), with a CFR of 5.8% (24/413). From 2001 to 2011, the age group of hospitalized patients was older (p = 0.03), and the number of deaths (p = 0.02) and the percentage of disease severity were lower (p = 0.06). Only disease severity remained associated to death in the multivariate analysis (OR = 3.2; 95%CI: 1.2-8.9; p = 0.02). CONCLUSION: When the 1996-2000 and 2001-2011 periods were compared, a significant reduction in CFR was observed in the latter, as well as a change in the clinical profile of the pediatric inpatients at the institute. These findings may be related to the improvement in the socio-economical status of the population. Penicillin use did not influence CFR.
Asunto(s)
Mortalidad Hospitalaria , Neumonía/mortalidad , Brasil/epidemiología , Niño , Preescolar , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/mortalidad , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Modelos Logísticos , Estudios Longitudinales , Masculino , Análisis Multivariante , Penicilina G/uso terapéutico , Neumonía/tratamiento farmacológico , Neumonía/epidemiología , Estudios Prospectivos , Factores de RiesgoRESUMEN
Objetivo: el objetivo del trabajo fue describir los resultados encontrados en los pacientes con neumonía neumocócica bacteriémica en nuestro medio y compararlos con otros ensayos similares. Pacientes y métodos: se realizó un estudio observacional retrospectivo de pacientes mayores de 15 años con neumonía aguda de la comunidad o neumonía intrahospitalaria con al menos un hemocultivo positivo para S. pneumoniae, internados desde enero 2004 hasta diciembre 2010. Resultados: se registraron 93 pacientes, 70 varones y 23 mujeres con una edad promedio de 50 años. La incidencia fue de siete casos cada 1.000 ingresos. Ningún paciente había recibido la vacuna antineumocócica antes de la internación. Se registraron 20 pacientes con HIV positivo y 5 pacientes con neumonía neumocócica intrahospitalaria. Los hábitos y comorbilidades más frecuente fueron el tabaquismo, etilismo, diabetes mellitus, EPOC, HIV y hepatopatía. Se constató en el grupo de bajo riesgo 42 pacientes. Se encontraron 87 muestras sensibles a penicilina, Se detectó una mortalidad del 9.6% y un promedio de once días de internación. El análisis multivariado determinó a las variables shock séptico y el alcoholismo como factores de riesgo de mortalidad. En 80 pacientes se redujo el tratamiento empírico endovenoso y en 46 se realizó de manera óptima. Conclusión: se describió en el trabajo la alta incidencia de neumonía neumocócica bacteriémica, los bajos niveles de resistencia del S. pneumoniae a la penicilina, la elevada reducción óptima antibiótica y el shock séptico y el alcoholismo como factores de riesgo de mortalidad
Objective: The objective was to describe the results found in patients with bacteremic pneumococcal pneumonia in our environment and compare them with similar trials. Patients and Methods: A retrospective observational study of patients older than 15 years with acute community-acquired pneumonia or hospital-acquired pneumonia with at least one positive blood culture for S. pneumoniae, admitted from January 2004 to December 2010 was performed. Results: 93 patients, 70 males and 23 females were recorded with an average age of 50 years. The incidence was seven cases per 1000 admissions. No patient had received pneumococcal vaccine before admission. 20 HIV positive patients and 5 patients with nosocomial pneumococcal pneumonia were recorded. Habits and most frequent comorbidities were smoking, alcohol consumption, diabetes mellitus, COPD, HIV and liver disease. It was found in the group of 42 low-risk patients. 87 penicillin-sensitive samples were found, a mortality of 9.6% and an average of eleven days in hospital was detected. Multivariate analysis determined the septic shock variables and alcohol as risk factors for mortality. In 80 patients the treatment was reduced empirical intravenous and 46 was performed optimally. Conclusion: the work described in the high incidence of bacteremic pneumococcal pneumonia, low levels of resistance of S. pneumoniae to penicillin, high optimal reduction and septic shock antibiotic and alcohol as risk factors for mortality
Asunto(s)
Masculino , Femenino , Humanos , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , VIH , Neumonía Bacteriana/microbiología , Neumonía Bacteriana/mortalidad , Neumonía Bacteriana/terapia , Neumonía Neumocócica/microbiología , Neumonía Neumocócica/mortalidad , Neumonía Neumocócica/terapia , Estudios Retrospectivos , Streptococcus pneumoniae/aislamiento & purificaciónRESUMEN
We evaluated the utility of blood cultures in the therapeutic management of patients with bacteremic pneumococcal pneumonia admitted to an internal medicine unit, in a retrospective observational study. Forty-nine patients were included, 75.5 percent were men, mean age 51.1 years. All S. pneumoniae strains were susceptible to penicillin. Four patients died. In 15.5 percent the treatment was modified narrowing antibiotic spectrum, in 51 percent cases it was changed to bencylpenicillin or amoxicillin exclusively, but only in 16 percent within the first 4 days. In 12 cases the prescription coincided with the oral switch therapy to amoxicillin. Due to the benefits and potential advantages of penicillin in diminishing the incidence of antibiotic resistance and reducing costs, it is important to work on prescription habits among physicians. This is especially important in the case of penicillin and the opportune moment of therapy change, improving the use of the microbiological report.
Evaluamos la utilidad de los hemocultivos en el manejo terapéutico de pacientes con neumonía neumocóccica bacteriémica internados en un servicio de clínica médica. Estudio observacional, retrospectivo. Se incluyeron 49 pacientes, 75,5 por ciento hombres, edad media 51,1 años. Todas las cepas de S. pneumoniae fueron susceptibles a penicilina. Fallecieron 4 pacientes. En 75,5 por ciento) se modificó el tratamiento con reducción del espectro antibacteriano, en 57 por ciento se cambió a bencilpenicilina o amoxicilina como único antimicrobiano, pero sólo en 16 por ciento se realizó dentro de los primeros cuatro días. En 12 casos la indicación coincidió con el cambio a vía oral por amoxicilina. Debido a los beneficios y ventajas potenciales de penicilina en mejorar el problema de la resistencia antimicrobiana, y en algunos casos reducir los costos, es importante trabajar sobre las prácticas de prescripción de los médicos clínicos, acerca de la indicación de penicilina y al momento oportuno del cambio, mejorando la utilización del informe microbiológico.
Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Bacteriemia/microbiología , Neumonía Neumocócica/microbiología , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Medios de Cultivo , Pruebas de Sensibilidad Microbiana , Neumonía Neumocócica/tratamiento farmacológico , Estudios Retrospectivos , Serotipificación , Índice de Severidad de la Enfermedad , Streptococcus pneumoniae/clasificación , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/aislamiento & purificaciónRESUMEN
The increasing reporting of Streptococcus pneumoniae resistance to penicillin has lead to the recommendation of third generation cephalospirins for the treatment of serious pneumococcal infections. As a consequence, clinicians usually do not prescribe first line antibiotics despiste the availability of susceptibility studies. Whit the aim to evaluate the impact of the infectious diseases specialist evaluation in the apropriate use oh the susceptibility studies, two series were compared: a historic control one (1998-2002, n = 50) and a prospectuve group that had the advisement of one infectious diseases specialist (2003-2006, n = 60). In both series, pneumonia stood out as the source of the bacteremia, and -alcoholism/hepatic insufficiency as associated factor. In the first series, 48 isolates resulted susceptible to penicillin by agar diffusion, and 1 out of 36 patients with pneumonia had a change in the antibiotic therapy to penicillin. In the prospective series, we found 56 susceptible isolates, and the remaining four were classified as intermediate susceptibility according to the MIC value. Antibiotics were changed in 36 out of 50 patients with bacteremic pneumococcal pneumonia (p < 0.05). The infectious diseases specialist evaluation had a positive impact on the use of the microbiological information for therapeutics purposes.
La descripción creciente de Streptococcus pneu-moniae resistente a penicilina, ha llevado a la recomendación de emplear cefalosporinas de tercera generación para el tratamiento de las infecciones neumo-cócicas graves. Como consecuencia, los médicos clínicos no prescriben, usualmente, antimicrobianos de primera línea, a pesar de disponer de estudios de susceptibilidad in vitro. Con el propósito de evaluar el impacto de la asesoría del infectólogo para el uso adecuado de los estudios de susceptibilidad, se compararon dos series: un control histórico (1998-2002, n = 50) y un grupo prospectivo en que sí hubo asesoría infectológica (2003-2006, n = 60). En ambas series, la neumonía fue el foco principal de bacteriemia y alcoholismo/falla hepática los factores asociados más frecuentes. En el primer grupo, 48 aislados resultaron susceptibles a penicilina por prueba de difusión en agar y en uno de 36 pacientes con neumonía, se efectuó cambio en la terapia antimicrobiana a bencilpeni-cilina. En el grupo prospectivo, hubo 56 cepas susceptibles y las cuatro restantes fueron clasificadas como de susceptibilidad intermedia, de acuerdo con los valores de CIM. Se cambió de antimicrobiano en 36 de 50 pacientes con neumonía neumocóccica bacteriémica (p < 0,05). La evaluación hecha por el infectólogo tuvo un impacto positivo en el uso de información micro-biológica con fines terapéuticos.
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Neumonía Neumocócica/tratamiento farmacológico , Streptococcus pneumoniae/efectos de los fármacos , Bacteriemia/microbiología , Estudios de Casos y Controles , Pruebas de Sensibilidad Microbiana , Resistencia a las Penicilinas , Estudios ProspectivosRESUMEN
The aim of the present work was to evaluate the usefulness of a simplified method for DNA extraction coupled to a nested-PCR protocol, based on the amplification of pneumolysin gene fragments for the diagnosis of pneumococcal pneumonia in pediatric patients with clinical and radiological evidence of bacterial infection. Bacterial DNA was extracted from sera by boiling and used without further purification in the PCR for the pneumolysin gene. None toxic reagents were used and the necessary steps to obtain the DNA were left at a minimum; furthermore, it overcomes the use of expensive commercial kits for DNA purification. The total procedure can be completed the same day of sampling and, most important, it avoids the use of sophisticated technology. Both in vitro analytical specificity and sensitivity (10 CFU/ml) of the assay were similar to those previously reported. When clinical samples were tested, the rate of positivity was shown to be 83.3% and 71% in pediatric patients with positive (group a) and negative blood cultures (group b), respectively. In group a, DNA detection was successful in samples from children without treatment or with less than 48 h of antibiotic therapy. None amplification was obtained from sera patients with viral infection or in samples from healthy controls. The application of the strategy described in this paper substantially seems to improve the diagnostic process in a determinate group: blood culture-negative children with pneumonia.
El objetivo del presente trabajo fue evaluar la utilidad de un método simplificado para extracción de ADN, acoplado a un protocolo de PCR anidada, basada en la amplificación de fragmentos del gen de la neumolisina para el diagnóstico de neumonía neumocócica en niños con evidencias clínicas y radiológicas de infección bacteriana. El ADN bacteriano fue extraído del suero por calentamiento y utilizado en la PCR para el gen de la neumolisina sin purificación posterior. Para la obtención de ADN no se utilizan reactivos tóxicos ni costosos "kits" comerciales. El procedimiento completo puede ser realizado en el día y lo que es más importante, evita el uso de tecnología sofisticada. La especificidad analítica in vitro y la sensibilidad (10 UFC/ml) del ensayo fueron similares a lo hallado en publicaciones anteriores. El porcentaje de muestras positivas fue del 83,3% y del 71% en los pacientes con hemocultivos positivos (grupo a) y negativos (grupo b), respectivamente. En el grupo a, sólo se obtuvieron resultados positivos mediante la PCR anidada en los pacientes no tratados o con menos de 48 hs de tratamiento antibiótico. No se obtuvieron señales de amplificación en los sueros de los pacientes con infecciones virales ni en las muestras del grupo control. La aplicación de la estrategia descripta incrementa la posibilidad diagnóstica de neumonía neumocócica en niños con hemocultivos negativos.